Combination therapy for invasive aspergillosis

Clinical Infectious Diseases

Volumn 39, Issue 6, 2004, Pages 803-805

  Viscoli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ASPERGILLOSIS; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DEATH; HEALTH CARE SYSTEM; HUMAN; MYCOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; SALVAGE THERAPY; SPECIES INVASION; SURVIVAL RATE; TREATMENT FAILURE;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; DRUG THERAPY, COMBINATION; HUMANS; OPPORTUNISTIC INFECTIONS; PEPTIDES, CYCLIC; PYRIMIDINES; TRIAZOLES;

EID: 4544250587     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/423389     Document Type: Note

References (12)

1. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358-66.
2. Johnson MD, MacDougall C, Ostrosky-Zeichner L, et al. Combination antifungal therapy. Antimicrob Agents Chemother 2004; 48:693-715.
3. Kirkpatrick WR, Perea S, Coco BJ, et al. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 2002; 46:2564-8.
4. Petraitis V, Petraitiene R, Sarafandi AA, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003; 187:1834-43.
5. Wheat LJ. Combination therapy for aspergillosis: is it needed, and which combination? J Infect Dis 2003; 187:1831-3.
6. Aliff TB, Maslak PG, Jurcic JG, et al. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer 2003; 97:1025-32.
7. Kontoyiannis DP, Hachem R, Lewis RE, et al. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 2003; 98:292-9.
8. Marr KA, Boeckh M, Carter Mstat RA, et al. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004; 39:797-802 (in this issue).
9. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342:1878-86.
10. Ioannidis JPA, Haidich AB, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001; 286:821-30.
11. Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186:1297-306.
12. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15:139-47.